2020
DOI: 10.1155/2020/7831675
|View full text |Cite
|
Sign up to set email alerts
|

Network Pharmacology Study of Heat‐Clearing and Detoxifying Traditional Chinese Medicine for Alzheimer′s Disease

Abstract: This study aims to explore the possible homologous mechanism of 7 frequently‐used herbs for heat-clearing and detoxification in traditional Chinese medicine (HDTCM) for treating Alzheimer's disease (AD), one of the most common types of dementia, based on network pharmacology. Herbs that satisfied the criteria of containing chlorogenic acid, relating to AD and aligning with HDTCM, were simultaneously collected to determine whether they have anti-AD effect based on a survey of the literature. Herb-ingredient-tar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 57 publications
(43 reference statements)
0
2
0
Order By: Relevance
“…tumulosic acid ((2R)-2-[(3S,5R,10S,13,14,16, 17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11, 12, 15,16,17-decahydro-1H-cyclopenta [a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid) is a novel, less frequently reported compound with oral bioavailability and drug-like properties of 29.88% and 0.81, respectively. Previous research has established that compounds with oral bioavailability ≥30% and drug-likeness ≥ 0.18 can become effective drugs ( Li L. et al, 2020 ; Li H. et al, 2020 ). Furthermore, based on the molecular docking results, tumulosic acid showed good binding activity to key targets, indicating that acid is likely to be the key active ingredient of Poria cocos against OC.…”
Section: Discussionmentioning
confidence: 99%
“…tumulosic acid ((2R)-2-[(3S,5R,10S,13,14,16, 17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11, 12, 15,16,17-decahydro-1H-cyclopenta [a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid) is a novel, less frequently reported compound with oral bioavailability and drug-like properties of 29.88% and 0.81, respectively. Previous research has established that compounds with oral bioavailability ≥30% and drug-likeness ≥ 0.18 can become effective drugs ( Li L. et al, 2020 ; Li H. et al, 2020 ). Furthermore, based on the molecular docking results, tumulosic acid showed good binding activity to key targets, indicating that acid is likely to be the key active ingredient of Poria cocos against OC.…”
Section: Discussionmentioning
confidence: 99%
“…40 Researchers also discovered that suppressing CASP3 expression decreased LPS-induced inflammation in astrocytes associated with neurotic plaques in AD. 41 Furthermore, NOS3 is a nitric oxide synthase (NOS), and studies have shown that the concentration of NOS is higher in patients with depression. 42 Inhibition of NOS3 in the dorsolateral periaqueductal gray matter can play a role in relieving anxiety.…”
Section: Discussionmentioning
confidence: 99%